Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra - PubMed (original) (raw)
Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra
P G Guyenet et al. Brain Res. 1978.
Abstract
In the present study dopamine (DA)-containing and other output neurons of the substantia nigra (SN) wer identified by antidromic stimulation from postulated target nuclei, the caudate-putamen, the thalamus, the cortex and the pontine reticular formation. To guide electrode placements, the topography of the nigrostriatal projection system was determined by retrograde tracing methods. Spontaneously active cells present in the SN were then classified in two groups according to the shape of their action potentials and their firing rate. Type I cells were located mainly in the pars compacta and could be antidromically-activated (AD-activated) from various locations along the course of the nigrostriatal pathway (caudate-putamen, globus pallidus, MFB) but not from other brain areas (ventromedial thalamus, motor cortex, pontine reticular formation). These neurons had a slow bursting pattern of firing, a very slow conduction velocity (0.58 m/sec), and a wide action potential. Their firing rate was dramatically reduced following the intravenous administration of apomorphine (ID 50: 9.3 microgram/kg), or the iontophoretic application of DA and GABA. Type II cells were located predominantly in the pars reticulata; most of them could be AD-activated from the ventromedial thalamus and the MFB but not from the motor cortex. A few of these cells could be AD-activated from the pontine reticular formation and the thalamus. A minority of type II cells, located in or near the pars compacta could be AD-activated from the caudate-putamen. In addition, their conduction velocuty was much higher (2.8 m/sec) and their firing rate far in excess of that exhibited by type I neurons. These neurons were inhibited by the iontophoretic application of GABA but not of DA. The microinjection of 6-hydroxydopamine (a neurotoxin relatively specific against catecholamine-containing neurons) in the vicinity of the MFB blocked selectively the propagation of antidromic spikes in type I but not type II cells. It is concluded that type I cells are the DA neurons of the nigrostriatal pathway. Type II cells are mainly oupput neurons that project to the ventromedial thalamus, the pons and the forebrain. This telencephalic projection most likely constitutes a second, non-DA, fast-conducting nigrostriatal pathway.
Similar articles
- Non-dopaminergic nigrostriatal pathway.
Guyenet PG, Crane JK. Guyenet PG, et al. Brain Res. 1981 Jun 1;213(2):291-305. doi: 10.1016/0006-8993(81)90235-3. Brain Res. 1981. PMID: 7248760 - Electrophysiological evidence for branching nigral projections to pontine reticular formation, superior colliculus and thalamus.
Niijima K, Yoshida M. Niijima K, et al. Brain Res. 1982 May 6;239(1):279-82. doi: 10.1016/0006-8993(82)90852-6. Brain Res. 1982. PMID: 7093682 - GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM, Lee CR. Tepper JM, et al. Prog Brain Res. 2007;160:189-208. doi: 10.1016/S0079-6123(06)60011-3. Prog Brain Res. 2007. PMID: 17499115 Review. - Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
Kim JS. Kim JS. Adv Biochem Psychopharmacol. 1978;19:217-33. Adv Biochem Psychopharmacol. 1978. PMID: 29447 Review.
Cited by
- Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.
Ugedo L, Grenhoff J, Svensson TH. Ugedo L, et al. Psychopharmacology (Berl). 1989;98(1):45-50. doi: 10.1007/BF00442004. Psychopharmacology (Berl). 1989. PMID: 2524859 - Dorsal raphé stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo.
Trent F, Tepper JM. Trent F, et al. Exp Brain Res. 1991;84(3):620-30. doi: 10.1007/BF00230974. Exp Brain Res. 1991. PMID: 1830848 - Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo.
Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Perra S, et al. Psychopharmacology (Berl). 2005 Dec;183(3):368-77. doi: 10.1007/s00213-005-0195-0. Epub 2005 Oct 15. Psychopharmacology (Berl). 2005. PMID: 16228194 - The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?
Margolis EB, Lock H, Hjelmstad GO, Fields HL. Margolis EB, et al. J Physiol. 2006 Dec 15;577(Pt 3):907-24. doi: 10.1113/jphysiol.2006.117069. Epub 2006 Sep 7. J Physiol. 2006. PMID: 16959856 Free PMC article. - TC-2559 excites dopaminergic neurones in the ventral tegmental area by stimulating alpha4beta2-like nicotinic acetylcholine receptors in anaesthetised rats.
Wang Y, Sherwood JL, Miles CP, Whiffin G, Lodge D. Wang Y, et al. Br J Pharmacol. 2006 Feb;147(4):379-90. doi: 10.1038/sj.bjp.0706621. Br J Pharmacol. 2006. PMID: 16402043 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous